Mechanisms of Disease: cell death in acute renal failure and emerging evidence for a protective role of erythropoietin
- 1 December 2005
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Clinical Practice Nephrology
- Vol. 1 (2), 87-97
- https://doi.org/10.1038/ncpneph0042
Abstract
Acute renal failure—characterized by a sudden loss of the ability of the kidneys to excrete nitrogenous waste, and to maintain electrolyte homeostasis and fluid balance—is a frequently encountered clinical problem, particularly in the intensive care unit. Unfortunately, advances in supportive interventions have done little to reduce the high mortality associated with this condition. Might erythropoietin (EPO) have utility as a therapeutic agent in acute renal failure? This hormone mediates anti-apoptotic effects in the bone marrow, facilitating maturation and differentiation of erythroid progenitors. New evidence indicates that EPO also exerts anti-apoptotic effects in the brain, heart and vasculature, which can limit the degree of organ damage. Here, we review the emerging biological role of EPO in the kidney and the pathophysiology of ischemia–reperfusion injury in an attempt to understand the therapeutic potential of EPO in acute renal failure.This publication has 82 references indexed in Scilit:
- Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivoKidney International, 2004
- Bone marrow–derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiationNature Medicine, 2004
- Erythropoietin protects against ischaemic acute renal injuryNephrology Dialysis Transplantation, 2004
- Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trialThe Lancet, 2003
- Hearts From Rodents Exposed to Intermittent Hypoxia or Erythropoietin Are Protected Against Ischemia-Reperfusion InjuryCell Metabolism, 2003
- ICAM-1 expression and leukocyte accumulation in inner stripe of outer medulla in early phase of ischemic compared to HgCl2-induced ARFKidney International, 2003
- Hospital-acquired renal insufficiencyAmerican Journal of Kidney Diseases, 2002
- Human, rat, and mouse kidney cells express functional erythropoietin receptorsKidney International, 1999
- JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietinCell, 1993
- The predictive value of 5′-adenine nucleotide depletion and replenishment in ischaemic rabbit kidney tissueInternational Urology and Nephrology, 1979